Monday, 18 March 2019
Subscribe to our RSS Feed
Subscribe
Want to Receive News & Updates from AHDB?
Stay up to date on the latest information you need to devise benefit designs, make coverage decisions, and further value-based healthcare! Sign up for our newsletter or print publications today by entering your contact information below and clicking "Subscribe".
First Name *
Last Name *
Email Address *
Email Address (Verify) *
We will request your mailing address on the next page.
 
American Health & Drug Benefits
  • Home
  • Issues
    • 2019
      • February 2019 - Vol 12 No 1
    • 2018
      • December 2018 Vol 11, No 9
      • November 2018 Vol 11, No 8
      • October 2018 Vol 11 No 7
      • September 2018 Vol 11, No 6
      • July 2018 - Vol 11 No 5
      • June 2018 - Vol 11 No 4
      • May 2018 - Vol 11 No 3
      • April 2018 - Vol 11 No 2
      • February 2018 - Vol 11 No 1
    • Issue Archive
    • Value-Based Care in Cardiometabolic Health
  • Special Issues
    • Supplements
    • 2019 Special Issues
      • January/February 2019, Vol 12, Special Issue: Payers’ Perspectives in Oncology: ASH 2018 Highlights
      • February 2019 - Vol 12 No 1 Supplement 1: Budget Impact of Omadacycline for the Treatment of Patients with Community-Acquired Bacterial Pneumonia in the United States from the Hospital Perspective
      • February 2019 - Vol 12 No 1 Supplement 2: Budget Impact Model of Omadacycline on Replacing a Proportion of Existing Treatment Options Among Patients Who Present to the Emergency Department with Acute Bacterial Skin and Skin Structure Infections
    • Special Issue Archive
  • Categories
  • Conference Correspondent
    • ASH 2018 - CLL
    • ID Week 2018
    • ASH 2017 - CLL
    • ACR 2017 - Rheumatoid Arthritis
    • ASCO 2017 - Chronic Lymphocytic Leukemia
    • ASCO 2017 - Acute Myeloid Leukemia
    • ASH 2016 - Multiple Myeloma
    • ASH 2016 - Chronic Lymphocytic Leukemia
  • Web Exclusives
    • All Web Exclusives
    • Drug Updates
    • FDA Approvals, News & Updates
    • In the News
    • Online First
    • Press Releases
    • Videos
  • For Authors
    • Call for Papers
    • Submit a Manuscript
    • Instructions for Authors
    • Join Peer Review
    • Permissions
  • About
    • About AHDB
    • About Engage HC
    • Contact Us
    • Editorial Policies
    • Peer-Review Process
    • Editorial Board
    • Editorial Process
    • Advertising Contacts
    • Advertising Policy
    • Reprints
    • Glossary

Hong Li, PhD

Dr Li is Group Director, Asia Pacific, Global Health Economics and Outcomes Research, Bristol-Myers Squibb Pharmaceutical Research Institute, Wallingford, CT.

Authored Items
Use Pattern and Off-Label Use of Atypical Antipsychotics in Bipolar Disorder, 1998-2002
Jeffery A. Demland, MS, Renee Rizzo Fleming, RPh, MBA, Yonghua Jing, BPharm, PhD, Christina M. L. Kelton, PhD, Jeff Jianfei Guo, MS, BPharm, PhD, Hong Li, PhD, Patricia R. Wigle, PharmD
June/July 2009, Vol 2, No 4 in Clinical
Prevalence of Treated Bipolar Disorders and Associated Comorbidities in Managed Care and Medicaid Populations
Jeff Jianfei Guo, MS, BPharm, PhD, Nirav R. Shah, MD,MPH, Nick C. Patel, PharmD, PhD, Hong Li, PhD, Paul E. Keck Jr., MD
May/June 2010, Vol 3, No 3 in Clinical
Last modified: September 6, 2013
  • Association for Value-Based Cancer Care
  • Value-Based Cancer Care
  • Value-Based Care in Rheumatology
  • Oncology Practice Management
  • Rheumatology Practice Management
  • Urology Practice Management
  • Inside Patient Care: Pharmacy & Clinic
  • Lynx CME
  • Home
  • About
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Advertising Policy
Copyright © 2019 Engage Healthcare Communications, LLC. All rights reserved.